Planned phase II trial of RG 7624 (NI-1401) in patients with autoimmune disorders
Latest Information Update: 22 Sep 2014
At a glance
- Drugs Afasevikumab (Primary)
- Indications Autoimmune disorders
- Focus Therapeutic Use
- Sponsors Genentech
- 22 Sep 2014 New trial record
- 05 Aug 2014 This trial is expected to be initiated in early 2015, according to a Novimmune media release.